Zhonghua zhong liu za zhi [Chinese journal of oncology]
-
Zhonghua Zhong Liu Za Zhi · Sep 2014
[Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
To analyze the clinical characteristics and survival depending on biological subtypes in breast cancer patients with brain metastases (BM). ⋯ The survival after BM is influenced by biological subtypes. Compared with the Luminal subtype, brain meatastases occurr earlier in HER-2-overexpressing and TNBC subtypes. Trastuzumab can delay the occurrence of BM from advanced breast cancer, and systemic therapy can improve the survival of patients after brain metastasis.